|

ASP2998 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Astellas Pharma Global Development, Inc.1

Indications

  • Locally Advanced or Metastatic Malignant Solid Tumors1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Hackensack, New Jersey1 trial

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

John Theurer Cancer Center at Hackensack University Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.